Human MDM2/ACTFS/hdm2 ORF/cDNA clone-Adenovirus particle (NM_002392)
Cat. No.: vGMAP-SPh-141
Pre-made Human MDM2/ACTFS/hdm2 Adenovirus for MDM2 overexpression in-vitro and in-vivo. The MDM2 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified MDM2-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
MDM2/HDM2/MDM2/ACTFS products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
| vGMAP-SPh-141 | Human MDM2 Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
| 5E+10PFU (1E+10pfu/ml×5ml) | |||
| 1E+11PFU (1E+10pfu/ml×10ml) | |||
| Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAP-SPh-141 |
| Gene Name | MDM2 |
| Accession Number | NM_002392 |
| Gene ID | 4193 |
| Species | Human |
| Product Type | Adenovirus particle (overexpression) |
| Insert Length | 1494 bp |
| Gene Alias | ACTFS,hdm2,HDMX |
| Fluorescent Reporter | EGFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGTGAGGAGCAGGCAAATGTGCAATACCAACATGTCTGTACCTACTGATGGTGCTGTAACCACCTCACAGATTCCAGCTTCGGAACAAGAGACCCTGGTTAGACCAAAGCCATTGCTTTTGAAGTTATTAAAGTCTGTTGGTGCACAAAAAGACACTTATACTATGAAAGAGGTTCTTTTTTATCTTGGCCAGTATATTATGACTAAACGATTATATGATGAGAAGCAACAACATATTGTATATTGTTCAAATGATCTTCTAGGAGATTTGTTTGGCGTGCCAAGCTTCTCTGTGAAAGAGCACAGGAAAATATATACCATGATCTACAGGAACTTGGTAGTAGTCAATCAGCAGGAATCATCGGACTCAGGTACATCTGTGAGTGAGAACAGGTGTCACCTTGAAGGTGGGAGTGATCAAAAGGACCTTGTACAAGAGCTTCAGGAAGAGAAACCTTCATCTTCACATTTGGTTTCTAGACCATCTACCTCATCTAGAAGGAGAGCAATTAGTGAGACAGAAGAAAATTCAGATGAATTATCTGGTGAACGACAAAGAAAACGCCACAAATCTGATAGTATTTCCCTTTCCTTTGATGAAAGCCTGGCTCTGTGTGTAATAAGGGAGATATGTTGTGAAAGAAGCAGTAGCAGTGAATCTACAGGGACGCCATCGAATCCGGATCTTGATGCTGGTGTAAGTGAACATTCAGGTGATTGGTTGGATCAGGATTCAGTTTCAGATCAGTTTAGTGTAGAATTTGAAGTTGAATCTCTCGACTCAGAAGATTATAGCCTTAGTGAAGAAGGACAAGAACTCTCAGATGAAGATGATGAGGTATATCAAGTTACTGTGTATCAGGCAGGGGAGAGTGATACAGATTCATTTGAAGAAGATCCTGAAATTTCCTTAGCTGACTATTGGAAATGCACTTCATGCAATGAAATGAATCCCCCCCTTCCATCACATTGCAACAGATGTTGGGCCCTTCGTGAGAATTGGCTTCCTGAAGATAAAGGGAAAGATAAAGGGGAAATCTCTGAGAAAGCCAAACTGGAAAACTCAACACAAGCTGAAGAGGGCTTTGATGTTCCTGATTGTAAAAAAACTATAGTGAATGATTCCAGAGAGTCATGTGTTGAGGAAAATGATGATAAAATTACACAAGCTTCACAATCACAAGAAAGTGAAGACTATTCTCAGCCATCAACTTCTAGTAGCATTATTTATAGCAGCCAAGAAGATGTGAAAGAGTTTGAAAGGGAAGAAACCCAAGACAAAGAAGAGAGTGTGGAATCTAGTTTGCCCCTTAATGCCATTGAACCTTGTGTGATTTGTCAAGGTCGACCTAAAAATGGTTGCATTGTCCATGGCAAAACAGGACATCTTATGGCCTGCTTTACATGTGCAAAGAAGCTAAAGAAAAGGAATAAGCCCTGCCCAGTATGTAGACAACCAATTCAAATGATTGTGCTAACTTATTTCCCCTAG |
| ORF Protein Sequence | MVRSRQMCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T00176-Ab | Anti-MDM2 monoclonal antibody |
| Target Antigen | GM-Tg-g-T00176-Ag | MDM2 protein |
| ORF Viral Vector | pGMLP005735 | Human MDM2 Lentivirus plasmid |
| ORF Viral Vector | pGMLV000680 | Human MDM2 Lentivirus plasmid |
| ORF Viral Vector | pGMLP-SPh-001 | Human MDM2 Lentivirus plasmid |
| ORF Viral Vector | pGMAP-SPh-141 | Human MDM2 Adenovirus plasmid |
| ORF Viral Vector | pGMPC001312 | Human MDM2 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | pGMPC004812 | Human MDM2 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | pGMPC004828 | Human MDM2 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | pGMPC004926 | Human MDM2 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP005735 | Human MDM2 Lentivirus particle |
| ORF Viral Vector | vGMLV000680 | Human MDM2 Lentivirus particle |
| ORF Viral Vector | vGMLP-SPh-001 | Human MDM2 Lentivirus particle |
| ORF Viral Vector | vGMAP-SPh-141 | Human MDM2 Adenovirus particle |
Target information
| Target ID | GM-T00176 |
| Target Name | MDM2/HDM2 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
4193 |
| Gene ID |
100052084 (Equus caballus), 17246 (Mus musculus), 314856 (Rattus norvegicus), 403693 (Canis lupus familiaris) 4193 (Homo sapiens), 493939 (Felis catus), 540378 (Bos taurus), 718284 (Macaca mulatta) |
| Gene Symbols & Synonyms | MDM2,Mdm2,edm2,Mdm-2,1700007J15Rik,HDMX,LSKB,hdm2,ACTFS |
| Target Alternative Names | 1700007J15Rik,ACTFS,Double minute 2 protein (Hdm2),E3 ubiquitin-protein ligase Mdm2,HDM2,HDMX,LSKB,MDM2,Mdm-2,Mdm2,Oncoprotein Mdm2,RING-type E3 ubiquitin transferase Mdm2,edm2,hdm2,p53-binding protein Mdm2 |
| Uniprot Accession |
P23804,P56950,P56951,Q00987,Q7YRZ8
Additional SwissProt Accessions: P56951,P23804,P56950,Q00987,Q7YRZ8 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | cancer, Breast Cancer |
| Disease from KEGG | Endocrine resistance, FoxO signaling pathway, p53 signaling pathway, PI3K-Akt signaling pathway, Cellular senescence, C-type lectin receptor signaling pathway, Thyroid hormone signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Epstein-Barr virus infection, Pathways in cancer, Proteoglycans in cancer, Glioma, Prostate cancer, Melanoma, Bladder cancer, Chronic myeloid leukemia |
| Gene Ensembl | ENSECAG00000013604, ENSMUSG00000020184, ENSCAFG00845016387, ENSG00000135679, ENSBTAG00000010422, ENSMMUG00000055447 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


